117 related articles for article (PubMed ID: 30089712)
1. Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis.
Hanjaya-Putra D; Haller C; Wang X; Dai E; Lim B; Liu L; Jaminet P; Yao J; Searle A; Bonnard T; Hagemeyer CE; Peter K; Chaikof EL
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089712
[TBL] [Abstract][Full Text] [Related]
2. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.
Song Y; Bienvenu LA; Bongcaron V; Prijaya SA; Maluenda AC; Walsh APG; McFayden JD; Pietersz GA; Peter K; Wang X
Theranostics; 2024; 14(8):3267-3281. PubMed ID: 38855181
[No Abstract] [Full Text] [Related]
3. Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy.
Ravishankar D; Salamah M; Attina A; Pothi R; Vallance TM; Javed M; Williams HF; Alzahrani EMS; Kabova E; Vaiyapuri R; Shankland K; Gibbins J; Strohfeldt K; Greco F; Osborn HMI; Vaiyapuri S
Sci Rep; 2017 Jul; 7(1):5738. PubMed ID: 28720875
[TBL] [Abstract][Full Text] [Related]
4. PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic mice.
Setiabakti NM; Tarlac V; Larsson P; Hamilton JR
J Thromb Haemost; 2024 Jan; 22(1):249-254. PubMed ID: 37827379
[TBL] [Abstract][Full Text] [Related]
5. Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis.
Sim MMS; Shiferawe S; Wood JP
Front Cardiovasc Med; 2023; 10():1272971. PubMed ID: 37937289
[TBL] [Abstract][Full Text] [Related]
6. Platelet mitochondria: the mighty few.
Ajanel A; Campbell RA; Denorme F
Curr Opin Hematol; 2023 Sep; 30(5):167-174. PubMed ID: 37459354
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk.
Chen J; Liu S; Ruan Z; Wang K; Xi X; Mao J
Blood Rev; 2024 Jun; ():101220. PubMed ID: 38876840
[TBL] [Abstract][Full Text] [Related]
8. Nutrition and Cardiovascular Disease: The Potential Role of Marine Bioactive Proteins and Peptides in Thrombosis Prevention.
Cheng S; Yuan L; Li-Gao R; Chen S; Li H; Du M
J Agric Food Chem; 2024 Apr; 72(13):6815-6832. PubMed ID: 38523314
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Drug Targets for Antiplatelet Therapy Specifically Targeting Platelets of Old Individuals through Proteomic Analysis.
Lee SH; Cho S; Lee JY; Hong JY; Kim S; Jeong MH; Kim WH
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001945
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Antithrombotic Therapy for Cancer-Associated Arterial Thromboembolism in Japan.
Xiong W; Yamashita Y
JACC CardioOncol; 2024 Apr; 6(2):298-299. PubMed ID: 38774005
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Thrombosis and Hemostasis-Part X.
Schulman S
Semin Thromb Hemost; 2024 May; ():. PubMed ID: 38733980
[No Abstract] [Full Text] [Related]
12. Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury.
Bienvenu LA; Maluenda A; McFadyen JD; Searle AK; Yu E; Haller C; Chaikof EL; Peter K; Wang X
Circ Res; 2020 Oct; 127(9):1211-1213. PubMed ID: 32806996
[No Abstract] [Full Text] [Related]
13. Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.
Ziegler M; Wang X; Peter K
Cardiovasc Res; 2019 Jun; 115(7):1178-1188. PubMed ID: 30906948
[TBL] [Abstract][Full Text] [Related]
14. Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis.
Liu H; Pietersz G; Peter K; Wang X
J Nanobiotechnology; 2022 Feb; 20(1):75. PubMed ID: 35135581
[TBL] [Abstract][Full Text] [Related]
15. Sulfated poly-amido-saccharides (sulPASs) are anticoagulants
Varghese M; Rokosh RS; Haller CA; Chin SL; Chen J; Dai E; Xiao R; Chaikof EL; Grinstaff MW
Chem Sci; 2021 Oct; 12(38):12719-12725. PubMed ID: 34703558
[TBL] [Abstract][Full Text] [Related]
16. A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices.
Abraham MK; Jost E; Hohmann JD; Searle AK; Bongcaron V; Song Y; Wendel HP; Peter K; Krajewski S; Wang X
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575580
[TBL] [Abstract][Full Text] [Related]
17. Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.
Orian JM; D'Souza CS; Kocovski P; Krippner G; Hale MW; Wang X; Peter K
Front Immunol; 2021; 12():620963. PubMed ID: 33679764
[TBL] [Abstract][Full Text] [Related]
18. Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications.
Peyron I; Kizlik-Masson C; Dubois MD; Atsou S; Ferrière S; Denis CV; Lenting PJ; Casari C; Christophe OD
Res Pract Thromb Haemost; 2020 Oct; 4(7):1087-1110. PubMed ID: 33134775
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for thrombosis: new targets and approaches.
Mackman N; Bergmeier W; Stouffer GA; Weitz JI
Nat Rev Drug Discov; 2020 May; 19(5):333-352. PubMed ID: 32132678
[TBL] [Abstract][Full Text] [Related]
20. Mending the failing heart.
Wang X; Peter K
Aging (Albany NY); 2019 Mar; 11(6):1605-1606. PubMed ID: 30886129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
